Medicine Plus,
Journal Year:
2024,
Volume and Issue:
1(2), P. 100027 - 100027
Published: May 2, 2024
In
recent
years,
gene
editing
technology,
represented
by
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)/CRISPR-associated
protein
9
(Cas9)
has
made
a
revolutionary
breakthrough.
Base
techniques
developed
from
CRISPR/Cas9
technologies
have
demonstrated
the
ability
to
efficiently
achieve
single
base
substitutions
at
specific
genomic
sites
without
double-strand
breaks.
systems
evolved
rapidly
over
past
few
efficient
single-base
high-throughput
screening,
and
in
vitro
vivo
applications.
particular,
screening
facilitated
functional
studies
single-nucleotide
resolution,
offering
unprecedented
insights
into
genetic
function.
Meanwhile,
rapid
advancement
of
artificial
intelligence
(AI)
is
playing
pivotal
role
assisting
genome
streamlining
data
analysis
within
systems.
This
review
encompasses
progress
research,
focusing
on
development
technologies,
exploring
editing-based
level,
underscoring
potential
synergies
between
AI
studies.
Cell,
Journal Year:
2023,
Volume and Issue:
186(18), P. 3983 - 4002.e26
Published: Aug. 1, 2023
Prime
editing
enables
a
wide
variety
of
precise
genome
edits
in
living
cells.
Here
we
use
protein
evolution
and
engineering
to
generate
prime
editors
with
reduced
size
improved
efficiency.
Using
phage-assisted
evolution,
efficiencies
compact
reverse
transcriptases
by
up
22-fold
generated
that
are
516–810
base
pairs
smaller
than
the
current-generation
editor
PEmax.
We
discovered
different
specialize
types
used
this
insight
outperform
PEmax
PEmaxΔRNaseH,
truncated
dual-AAV
delivery
systems.
Finally,
Cas9
domains
improve
editing.
These
resulting
(PE6a-g)
enhance
therapeutically
relevant
patient-derived
fibroblasts
primary
human
T-cells.
PE6
variants
also
enable
longer
insertions
be
installed
vivo
following
delivery,
achieving
40%
loxP
insertion
cortex
murine
brain,
24-fold
improvement
compared
previous
state-of-the-art
editors.
Cell,
Journal Year:
2024,
Volume and Issue:
187(10), P. 2411 - 2427.e25
Published: April 11, 2024
We
set
out
to
exhaustively
characterize
the
impact
of
cis-chromatin
environment
on
prime
editing,
a
precise
genome
engineering
tool.
Using
highly
sensitive
method
for
mapping
genomic
locations
randomly
integrated
reporters,
we
discover
massive
position
effects,
exemplified
by
editing
efficiencies
ranging
from
∼0%
94%
an
identical
target
site
and
edit.
Position
effects
efficiency
are
well
predicted
chromatin
marks,
e.g.,
positively
H3K79me2
negatively
H3K9me3.
Next,
developed
multiplex
perturbational
framework
assess
interaction
trans-acting
factors
with
outcomes.
Applying
this
DNA
repair
factors,
identify
HLTF
as
context-dependent
repressor
editing.
Finally,
several
lines
evidence
suggest
that
active
transcriptional
elongation
enhances
Consistent
this,
show
can
robustly
decrease
or
increase
preceding
it
CRISPR-mediated
silencing
activation,
respectively.
Nature Biotechnology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 12, 2024
Tumor
genomes
often
harbor
a
complex
spectrum
of
single
nucleotide
alterations
and
chromosomal
rearrangements
that
can
perturb
protein
function.
Prime
editing
has
been
applied
to
install
evaluate
genetic
variants,
but
previous
approaches
have
limited
by
the
variable
efficiency
prime
guide
RNAs.
Here
we
present
high-throughput
sensor
strategy
couples
RNAs
with
synthetic
versions
their
cognate
target
sites
quantitatively
assess
functional
impact
endogenous
variants.
We
screen
over
1,000
cancer-associated
variants
TP53-the
most
frequently
mutated
gene
in
cancer-to
identify
alleles
p53
function
mechanistically
diverse
ways.
find
certain
TP53
particularly
those
oligomerization
domain,
display
opposite
phenotypes
exogenous
overexpression
systems.
Our
results
emphasize
physiological
importance
dosage
shaping
native
stoichiometry
protein-protein
interactions,
establish
framework
for
studying
sequence
context
at
scale.
Nature Biomedical Engineering,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 10, 2024
Abstract
Prime
editing
(PE)
enables
precise
and
versatile
genome
without
requiring
double-stranded
DNA
breaks.
Here
we
describe
the
systematic
optimization
of
PE
systems
to
efficiently
correct
human
cystic
fibrosis
(CF)
transmembrane
conductance
regulator
(
CFTR
)
F508del,
a
three-nucleotide
deletion
that
is
predominant
cause
CF.
By
combining
six
efficiency
optimizations
for
PE—engineered
guide
RNAs,
PEmax
architecture,
transient
expression
dominant-negative
mismatch
repair
protein,
strategic
silent
edits,
PE6
variants
proximal
‘dead’
single-guide
RNAs—we
increased
correction
efficiencies
F508del
from
less
than
0.5%
in
HEK293T
cells
58%
immortalized
bronchial
epithelial
(a
140-fold
improvement)
25%
patient-derived
airway
cells.
The
also
resulted
minimal
off-target
editing,
edit-to-indel
ratios
3.5-fold
greater
those
achieved
by
nuclease-mediated
homology-directed
repair,
functional
restoration
ion
channels
over
50%
wild-type
levels
(similar
via
combination
treatment
with
elexacaftor,
tezacaftor
ivacaftor)
primary
Our
findings
support
feasibility
durable
one-time
Cell Reports Medicine,
Journal Year:
2024,
Volume and Issue:
5(5), P. 101544 - 101544
Published: May 1, 2024
Prime
editing
is
a
recent,
CRISPR-derived
genome
technology
capable
of
introducing
precise
nucleotide
substitutions,
insertions,
and
deletions.
Here,
we
present
prime
approaches
to
correct
L227R-
N1303K-CFTR,
two
mutations
that
cause
cystic
fibrosis
are
not
eligible
for
current
market-approved
modulator
therapies.
We
show
that,
upon
DNA
correction
the
CFTR
gene,
complex
glycosylation,
localization,
and,
most
importantly,
function
protein
restored
in
HEK293T
16HBE
cell
lines.
These
findings
were
subsequently
validated
patient-derived
rectal
organoids
human
nasal
epithelial
cells.
Through
analysis
predicted
experimentally
identified
candidate
off-target
sites
primary
stem
cells,
confirm
previous
reports
on
high
editor
(PE)
specificity
its
potential
curative
CF
gene
therapy.
To
facilitate
future
screening
genetic
strategies
translational
model,
machine
learning
algorithm
was
developed
dynamic
quantification
(DETECTOR:
"detection
targeted
organoids").
Science,
Journal Year:
2025,
Volume and Issue:
387(6733)
Published: Jan. 30, 2025
We
lack
tools
to
edit
DNA
sequences
at
scales
necessary
study
99%
of
the
human
genome
that
is
noncoding.
To
address
this
gap,
we
applied
CRISPR
prime
editing
insert
recombination
handles
into
repetitive
sequences,
up
1697
per
cell
line,
which
enables
generating
large-scale
deletions,
inversions,
translocations,
and
circular
DNA.
Recombinase
induction
produced
more
than
100
stochastic
megabase-sized
rearrangements
in
each
cell.
tracked
these
over
time
measure
selection
pressures,
finding
a
preference
for
shorter
variants
avoided
essential
genes.
characterized
29
clones
with
multiple
rearrangements,
an
impact
deletions
on
expression
genes
variant
but
not
nearby
This
genome-scrambling
strategy
large
sequence
relocations,
insertion
regulatory
elements
explore
dispensability
organization.
Molecular Cell,
Journal Year:
2023,
Volume and Issue:
83(24), P. 4633 - 4645.e9
Published: Dec. 1, 2023
Despite
tremendous
progress
in
detecting
DNA
variants
associated
with
human
disease,
interpreting
their
functional
impact
a
high-throughput
and
single-base
resolution
manner
remains
challenging.
Here,
we
develop
pooled
prime-editing
screen
method,
PRIME,
that
can
be
applied
to
characterize
thousands
of
coding
non-coding
single
experiment
high
reproducibility.
To
showcase
its
applications,
first
identified
essential
nucleotides
for
716
bp
MYC
enhancer
via
PRIME-mediated
analysis.
Next,
PRIME
functionally
1,304
genome-wide
association
study
(GWAS)-identified
breast
cancer
3,699
from
ClinVar.
We
discovered
103
156
uncertain
significance
are
affecting
cell
fitness.
Collectively,
demonstrate
is
capable
characterizing
genetic
at
scale,
advancing
accurate
genome
annotation
disease
risk
prediction,
diagnosis,
therapeutic
target
identification.